A literature review and our own data are presented to demonstrate that urinary albumin (UA) excretion increases in many renal disorders and that it offers a far more sensitive indicator than the commonly used urinary total protein (UTP) for the early detection of renal involvement in many chronic diseases such as diabetes mellitus, hypertension, and systemic lupus erythematosus. In many individuals with these disorders, UA increases severalfold, even while UTP remains within the reference interval. UA is also more suited than UTP for following therapeutic responses in these slowly progressive renal disorders. Increases in UA are associated with increased mortality. UTP measurements are plagued with many analytical problems, whereas UA is much easier to standardize. We recommend that both UA and UTP be measured when quantitative unne protein assays are ordered, especially when the UTP is <300 mg/g of creatinine.
. This reference interval for UA is based on assays of UA in random (untimed) daytime urine specimens from 80 healthy adults (1) and is in close agreement with the reference interval of 0.2-2.8 glmol of creatinine reperted by Silver et al. (2) . UA excretion has been also reported as mg/24 h or g/min. Many workers use 30 mg/24 h as the upper limit of the UA reference interval (3-6), although different reference intervals or cutoff values may be set for special studies. Even with a fivefold increase in UA, the UTP values may remain <200 mg/g of creatinine (i.e., within the UTP reference interval) and be interpreted, falsely, as clinically normal. The most common proteinuria screen is the "dipstick," with a sensitivity for urinary protein (mainly albumin) of 150-300 mgfL, which is suitable only for detecting relatively gross albuminuria.
In 1982 Viberti et al. (7) , using a radioimmunoassay, found that an increased rate of albumin excretion could predict the onset of nephropathy in insulin-dependent diabetics, even when the UTP test was within the reference interval. This observation has been confirmed by several other groups (4,8-10). Viberti eta!. (7) coined the term "microalbuminuria" to refer to the measurement of an increased UA with UTP within the reference interval or with a negative dipstick result. Microalbuminuria has been defined also as albumin excretion of 30-300 mg/24 h (4, 5). This term has become very common in the literature and, unfortunately, is likely to remain with us even though, in traditional protein nomenclature, the prefix "micro" is used to indicate a (17) . Many patients with systemic lupus erythematosus show increased albumin excretion before developing structural renal changes (18); again, the albumin excretion decreases in response to cortisol treatment (18) . Increased UA excretion occurs in pre-eclampsia (19) We have seen a nearly eightfold increase in UA above the reference interval in six hospital patients taking gentamicin or tobramycin, drugs known to cause tubular proteinuria. Tubular proteinuria is, however, detected more specifically by increases in urine excretion of low-molecular- A modest increase in albumin excretion also occursin overflow proteinuria, e.g., Bence Jones proteinuria, myoglobinuria, and hemoglobinuria (Table 2 ). For proper diagnosis of these disorders, specific protein assays (immunoassays and electrophoresis) are more suitable. A greater increase in UTP than in UA suggestsan overflow proteinuria.
Benign proteinuria (mainly albuminuria) will be detected by either UA or UTP assays. Acute renal failure is usually associated with a rapid onset of clinical symptoms and a greater increase of UTP, with albumin the major protein. In these cases, UA assays yield the same information as UTP assays.
As renal disease progresses in diabetes and hypertension, the UA/IJTP fraction is quite variable but generally increases. For example, when UTP is less than 100 mg/g of creatinine, UA.ItJTP is about 20%. As UTP approaches 200 mg/g of creatinine, the UA!UTP increases to about 50%. With some exceptions, when the UTP exceeds 1000 mg/g of creatinine, UA/UTP approaches 80% (1). Thus, a UTP of 1000 mgfL may represent only a fivefold increase over the reference range for IJTP but a 25-fold increase for UA. For this reason, UA will be increased more than UTP and also in a greater percentage of the patients, especially when IJTP is only marginally increased ( Table 2 ). The UA/ UTP ratio may prove useful for evaluating renal status.
In diabetics, the filtration of some proteins such as transferrin (31) and free sclight chains (32,33) increases more than that of albumin because of their higher isoelectric point (31). Measurement of urinary excretion of these proteins has, as yet, no demonstrated advantage over UA determination. Compared with IJA, these proteins are more difficult and thus less convenient to assay. Furthermore, our preliminary data show that, whereas albumin excretion is increased in essential hypertension in humans, transferrin excretion is not.
AnalytIcal Aspects
The assay of UTP is plagued by several major problems: many interfering substances,poor reproducibility at low ranges, and different sensitivities to different proteins by various assay techniques. Many colorimetric methods are used to assay UTP in addition to several common semiquantitative screening methods, e.g., dipsticks, precipitation, and heat and acid tests. The lack of sensitivity of the dipsticks for UTP is evident from the data in Table 2 (1, 37, 38), and latex particle (39) imniunoassays have been described for UA determination, involving the use of polyethylene and latex particles to enhance the sensitivity and the speed of the reaction .  Radial immunodiffusion (1), fluoroimmunoassay (2,40) , and enzyme immunoassay (41) methods have also been described for determining UA. The advantages and disadvantages of these various methods have been discussed (5, 42) .
UA assays are adaptable to the automated instruments used in the routine laboratory with a reagent cost per test for UA similar to that for UTP. Some UA immunoassays are, however, subject to problems from the prozone effect in the presence of antigen excess. Because the UA concentration can range over several orders of magnitude, special care should be taken to select methods that can detect antigen excess. Specific colorimetric and fluorometric assayswould be desirable. In the near future, automated capillary electrophoresis may prove suitable for UA measurement; it has the sensitivity to measure low values and can incorporate internal standards.
UA excretion is quite variable in the individual, with reported CVs ranging from 45% (3, 9) to 100% (5) . Random (untimed) urine samples have more variability than do 24-h collections, but indexing the UA of untimed samples to creatinine excretion reduces some of the variability. Because of this increased variability, the reference interval for untimed samples is slightly wider than that based on 24-h collections (5). From a practical point of view, untimed samples are more convenient for the patient and thus are recommended by someworkers (5) ; some workers prefer a morning sample (43). Exercise (4, 9, 31), posture (44) , and diuresis (45) affect UA. The effects of diet (e.g., salt or high protein) on UA have not been studied adequately. Because UA changes over a very wide range (up to 100-fold), a slight increase in an untimed sample might not be significant. Given the variability in UA excretion, some workers use two to three samples (3, 9) to verify above-normal values. For slowly progressive disorders, the change in UA over time may be more important than an isolated single value (9).
Conclusion
UA is a more specific and sensitive indicator of a wide variety of renal disorders than is UTP. In the Framingham study (46), individuals with persistent proteinuria (mainly UA) and increased risk for cardiovascular disease had a higher mortality rate. A recent editorial in Diabetic Medicine (47) stated that measurements of UA and glycohemoglobin were the two major advances of the 1980s in care for diabetes patients. Because of the lack of studies of UA as a marker of renal disorders other than in diabetes, UA has not been widely used in general clinical medicine. Yet, in our experience, about 20% of the hospital patients' samples requested for UTP that yield values between 100 and 300 mg/g of creatinine will have about a threefold increase above the upper limit of the reference interval for UA.
Answers to several practical and basic questions also must precede the widespread use of this test. What is the best sample to collect? How long can samples be stored?What medication and dietary and physiological factors affect the excretion of albumin? What is the basic mechanism for increased excretion in different disorders? Additionally, it is important to investigate the various renal disorders, including tubular and acute renal disorders, that might causeincreases in UA and to assess the clinical value of this information for patient treatment. These questions should not be discouraging, but rather should be seen as an exciting new opportunity for the clinician, pathologist, and clinical chemist to pursue knowledge to improve patient care.
Thus, we advocate the addition of a UA assay to the measurement of UTP for patients presenting with normal UTP or a borderline increase in UTP (100-300 mg/g of creatinine) and for patients who might be at risk of developing chronic renal disease. This practice will detect these disorderswith better specificity and greater sensitivity. Because UA increases in a wide variety of renal disorders, UA concentrations can be used to follow the course of disease and signal the necessity for early treatment when the diseasemight be reversible. Results must be interpreted in light of the patient's history. However, UA is most useful in following the course of slowly progressive disorders. The ratio of UA/UTP adds extra information for patient diagnosis. The addition of UA testing to samples with normal UTP values would augment the clinical significance of UTP and enhance the detection of chronic renal disorders.
